SANTINI GINO 4
4 · COLLEGIUM PHARMACEUTICAL, INC · Filed May 18, 2026
Research Summary
AI-generated summary of this filing
Collegium (COLL) Director Gino Santini Receives RSU Award
What Happened Gino Santini, a director of Collegium Pharmaceutical, was granted 8,741 restricted stock units (RSUs) on May 14, 2026. The grant was reported on a Form 4 filed May 18, 2026. The RSUs were awarded at $0.00 per unit (grant award rather than a purchase), so no cash changed hands at grant and the immediate reported value is $0.
Key Details
- Transaction date: 2026-05-14; Form 4 filed: 2026-05-18 (filed within the typical 2 business-day window).
- Transaction code: A (award/grant). Amount: 8,741 RSUs; Price per share reported: $0.00; immediate reported value: $0.
- Vesting/settlement (per footnote): RSUs vest on the earlier of May 14, 2027 or the Issuer’s 2027 Annual Meeting, subject to continued board service. RSUs will be settled in shares on that date or, at the director’s election, earlier upon end of service, death/disability, or a change in control.
- Shares owned after the reported transaction: not specified in the provided filing details.
Context RSU grants to non-employee directors are common compensation and do not represent an open-market purchase (so they’re routine rather than a direct bullish market signal). RSUs are a contingent right to receive shares upon vesting; tax consequences and actual share ownership occur on settlement/vesting.
Insider Transaction Report
- Award
Common Stock
[F1]2026-05-14+8,741→ 103,783 total
Footnotes (1)
- [F1]Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the earlier of May 14, 2027, or the date of the Issuer's 2027 Annual Meeting of Shareholders, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock.